Skip to main content

Read the latest news about research and scientific resultats on Alzheimer's disease at the Barcelonaβeta Brain Research Center (BBRC).

17 Apr | 2026

New study in cognitively healthy adults highlights the unique sensitivity of tau PET in the early stages of Alzheimer's

Fluid biomarkers remain highly valuable but are not yet sensitive enough to detect the earliest tau changes.

07 Apr | 2026

How the environment influences biological brain ageing

An international study involving data from the ALFA+ cohort shows that the combination of physical and social environmental exposures is a major driver of accelerated or delayed brain aging.

25 Mar | 2026

Alzheimer’s genetic risk affects women and men differently years before symptoms appear

A study by the BBRC shows that the genetic risk of Alzheimer’s disease may manifest itself differently in women and men, paving the way for more personalised prevention strategies.

18 Feb | 2026

BBRC researchers take part in a Nature Aging study validating blood biomarkers in diverse populations

The study strengthens the validity of blood-based biomarkers for detecting Alzheimer’s disease and other dementias in diverse population settings, representing a key step towards more accessible and equitable diagnosis

12 Feb | 2026

Study links locus coeruleus status to deep sleep quality in aging and Alzheimer's disease

This research describes new mechanisms linking the locus coeruleus to deep sleep and reveals differences according to sex and cerebral vascular status.

09 Feb | 2026

A standardised protocol reduces post-lumbar puncture headache after cerebrospinal fluid extractions

The study analysed 1147 lumbar punctures performed on 724 participants in the ALFA study

18 Dec | 2025

BBRC researchers contribute to landmark Springer Volume on biomarkers of neurodegenerative disorders

The book is leading reference on biomarkers shaping diagnosis, prognosis, and therapy development in Alzheimer’s disease and related dementias.

03 Nov | 2025

New study reveals sex differences in cerebrospinal fluid biomarkers of Alzheimer’s disease prior to symptom onset

These findings reinforce the robustness of current CSF tools for early detection while encouraging sex-aware interpretation when tracking disease biology over time

25 Sep | 2025

We confirm the use of the p-tau217 blood biomarker to detect Alzheimer's disease in its early stages

The international study shows that this biomarker allows detection of the presence of amyloid beta deposits, a key pathology in the development of the disease, in individuals without cognitive impairment